- BRP Home
- Priority Areas
- Funding Opportunities
- Data and Tools
- About BRP
Research Area: Tobacco use and cessation among cancer patients, tobacco use and cancer chemoprevention and screening, clinical trials
Stephanie Land, Ph.D., is a Program Director and Statistician in the Behavioral Research Program Tobacco Control Research Branch (TCRB) at the National Cancer Institute (NCI). Her areas of focus are tobacco use among patients in the settings of cancer prevention, screening, treatment, and survivorship. She is chair of the Division of Cancer Control and Population Science Clinical Trials Coordination Group and Associate Editor for the Journal of Clinical Oncology. She is also a former member of the NCI Special Studies Institutional Review Board and is currently a member of the NCI Clinical Trials Stewardship Working Group and the CPCRN Tobacco/Lung Cancer Working Group. She serves on the American Association for Cancer Research (AACR) Tobacco and Cancer Subcommittee and is chair of the NCI-AACR Cancer Patient Tobacco Use Assessment Task Force.
Before joining NCI, Dr. Land was co-founder and director of the Reduce Smoking and Exposure to Tobacco (ReSET) Center, an Associate Professor of Biostatistics at the University of Pittsburgh, and a member of the American Schools of Public Health Tobacco Use Council. She has twice served as principal investigator. In one project, she led an NCI-funded study on smoking and other lifestyle behaviors as predictors of patient adherence to chemoprevention in the setting of breast cancer. The second project was an intramurally funded study of tobacco use and social network formation during the first year of college.>
Dr. Land has more than 90 research publications in print. From 1999-2011, she was a statistician in the National Surgical Adjuvant Breast and Bowel Project (NSABP), an NCI-funded clinical trials cooperative group that conducted multi-center phase III trials for breast and colorectal cancer. Her primary role in the NSABP was as the lead statistician for the Behavioral and Health Outcomes Program. She has also collaborated with members of the University of Pittsburgh Cancer Institute Lung and Thoracic Malignancies Program since 1999 and served as the lead statistician for the Lung Cancer Specialized Program of Research Excellence (SPORE) from 2002-11, directing the Core through two competing renewals. Before coming to NCI, Dr. Land participated in the Community Clinical Oncology Program (CCOP) Research Priorities Strategic Planning Committee (NCI), Subcommittee H (reviewing cooperative groups), the NCI Symptom Management and Quality of Life Scientific Steering Committee, and numerous NCI grant review panels. Dr. Land earned a doctorate in statistics from Stanford University in 1995.
Current and past mentors include Sarah Kobrin.
Current and past BRP mentees include Elizabeth Seaman.
Kaufman, A.R., Land, S., Parascandola, M., Augustson, E., Backinger, C.L. Tobacco Use Transitions: The National Longitudinal Study of Adolescent Health. Prev Med 2015; 81:251-257.
Land, S.R. & Marcus, P.M. Cancer screening and diagnosis: opportunities for smoking cessation intervention. J Clin Oncol 2015; 33(15):1631-1632.
Land, S.R., Walcott, F.L., Liu, Q., Wickerham, D.L., Costantino, J.P., & Ganz, P.A. Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1. J Natl Cancer Inst 2015; 108(4).
Land, S.R., Toll, B.A., Moinpour, C.M., et al. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clin Cancer Res 2016; 22(8):1907-1913.
Land, S.R., Warren, G.W., Crafts, J.L., et al. Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer 2016; 122(11):1728-1734.